ML
Therapeutic Areas
Indivior PLC Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RBP-6300 (risperidone) | Schizophrenia | Phase 3 |
| INV-202 | Cocaine Use Disorder | Phase 2b |
| SUBLOCADE® | Opioid Use Disorder | Marketed |
| PERSERIS® | Schizophrenia | Marketed |
| Drug | Indication | Phase |
|---|---|---|
| RBP-6300 (risperidone) | Schizophrenia | Phase 3 |
| INV-202 | Cocaine Use Disorder | Phase 2b |
| SUBLOCADE® | Opioid Use Disorder | Marketed |
| PERSERIS® | Schizophrenia | Marketed |